I said yes to an Alzheimer’s blood test. Then I panicked.
New blood-based diagnostic platforms for Alzheimer’s disease have triggered a shift in medical testing and patient apprehension.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Circular Genomics has launched its CircPATH platform, a tool designed for the early detection of Alzheimer’s disease. Simultaneously, Medical News Today and Medical Xpress are reporting on the emergence of the SECmere blood test and findings regarding blood proteins that may indicate dementia risk.
Coverage from The Washington Post highlights the psychological response to receiving results from such tests. Future reports will likely address the clinical adoption of these testing platforms.
It remains to be determined how the medical community will manage the diagnostic process alongside the emotional impact on patients receiving early detection results.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (71% supported) Updated 45d ago.
Quick answers
What is the CircPATH platform?
It is a new diagnostic platform from Circular Genomics designed for the early detection of Alzheimer’s disease.
What do the new blood tests detect?
Coverage indicates these tests utilize circular RNAs and specific blood proteins to identify Alzheimer's-related changes.
How early can these tests identify risk?
According to Medical Xpress, certain blood proteins can flag dementia risk decades before symptoms appear.
Coverage (9)
- New Alzheimer’s blood test may tell when symptoms are around the corner Florida Hospital News and Healthcare Report · 45d ago
- Can a blood test predict dementia? 4 latest studies show promise Medical News Today · 45d ago
- What Blood Tests Could Mean for Early Alzheimer’s Detection Being Patient · 45d ago
- Lighting up the way to faster, cheaper diagnosis of Alzheimer's disease Alzheimer's Society · 45d ago
- Circular Genomics Unveils Its CircPATH™ Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease Newswise · 45d ago
- New ‘SECmere’ blood test could spot Alzheimer’s-related changes sooner Medical News Today · 45d ago
- A blood protein can flag dementia risk decades before symptoms appear Medical Xpress · 45d ago
- Blood-based circular RNAs for early diagnosis of Alzheimer’s disease Nature · 45d ago
- I said yes to an Alzheimer’s blood test. Then I panicked. The Washington Post · 45d ago
Topics
Related trends
Two Hours of Sleep Restored in Alzheimer’s Brains in Research Breakthrough
New research indicates that two hours of sleep can be restored in brains affected by Alzheimer's disease without targeting amyloid plaques.
The best and worst supplements for your brain
Neurologists and health experts are weighing in on the efficacy of brain supplements, specifically warning against Ginkgo Biloba while promoting dietary shifts.
A new target in the gut for reducing Alzheimer's risk
New research from UW–Madison and PUCMM explores how the gut microbiota may be a target for reducing the risk of Alzheimer's and cognitive decline.
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
Advances in Alzheimer's blood tests are promising earlier diagnosis but triggering significant emotional distress and confusion for patients.
One cognitive ability stood out in a study of Western diets and Alzheimer’s risk genes - News-Medical
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
This Nighttime Habit Could Be A Key Indicator Of Dementia. Neurologists Explain The Warning Signs
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.